Cargando…
N-acetylglucosamine inhibits inflammation and neurodegeneration markers in multiple sclerosis: a mechanistic trial
BACKGROUND: In the demyelinating disease multiple sclerosis (MS), chronic-active brain inflammation, remyelination failure and neurodegeneration remain major issues despite immunotherapy. While B cell depletion and blockade/sequestration of T and B cells potently reduces episodic relapses, they act...
Autores principales: | Sy, Michael, Newton, Barbara L., Pawling, Judy, Hayama, Ken L., Cordon, Andres, Yu, Zhaoxia, Kuhle, Jens, Dennis, James W., Brandt, Alexander U., Demetriou, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10498575/ https://www.ncbi.nlm.nih.gov/pubmed/37705084 http://dx.doi.org/10.1186/s12974-023-02893-9 |
Ejemplares similares
-
Association of a Marker of N-Acetylglucosamine With Progressive Multiple Sclerosis and Neurodegeneration
por: Brandt, Alexander U., et al.
Publicado: (2021) -
N-acetylglucosamine drives myelination by triggering oligodendrocyte precursor cell differentiation
por: Sy, Michael, et al.
Publicado: (2020) -
Increasing cell permeability of N-acetylglucosamine via 6-acetylation enhances capacity to suppress T-helper 1 (T(H)1)/T(H)17 responses and autoimmunity
por: Lee, Sung-Uk, et al.
Publicado: (2019) -
Mitochondrial dysfunction and neurodegeneration in multiple sclerosis
por: Su, Kimmy, et al.
Publicado: (2013) -
Iron and Neurodegeneration in Multiple Sclerosis
por: Khalil, Michael, et al.
Publicado: (2011)